Results 81 to 90 of about 2,582 (154)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?

open access: yesFrontiers in Oncology, 2019
Purpose: The oligometastatic state is a proposed entity between localized cancer and widely metastatic disease, comprising an intermediate subset of metastatic cancer patients.
Faiez Al-Shafa   +5 more
doaj   +1 more source

Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification

open access: yesCancer Medicine, Volume 14, Issue 24, December 2025.
ABSTRACT Aim Although Japanese expert consensus introduced the borderline resectable (BR) criteria, additional classification is considered necessary for clinical practice. This study aimed to evaluate the prognostic predictive value of the modified BR (mBR) criteria.
Fujimasa Tada   +24 more
wiley   +1 more source

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis [PDF]

open access: yes, 2018
Background: Precise local radiotherapy for adrenal metastasis can prolong the useful life of patients with oligometastasis. The aim of this retrospective, 2-center study was to establish the safety and effectiveness of real-time tumor-tracking ...
Katoh, Norio   +9 more
core   +1 more source

Additional file 1 of Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy

open access: yes, 2023
Additional file 1: Table 1. Category and dosage of target medicine and PD-1 inhibitors. Table 2. Two groups of PD-1 inhibitors combined with targeted therapy. Table 3.
Zhe Sun (328682)   +8 more
core   +1 more source

Quality of Life of Oligometastatic and Polymetastatic Head and Neck Squamous Cell Carcinoma Patients [PDF]

open access: yes
Objective: Evidence suggests that distant metastasis in head and neck squamous cell carcinoma is a spectrum of disease. Previous studies show that oligometastasis has favorable survival compared with polymetastasis.
Berzenji, Diako   +6 more
core   +1 more source

Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma

open access: yes, 2021
Purpose: For bone metastasis from hepatocellular carcinoma (HCC), radiotherapy (RT) has been used a palliative treatment with little impact on survival. Currently, ablative RT is popularly used, and a more than palliative effect is expected.
최치환   +3 more
core   +1 more source

Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progressionResearch in context

open access: yesEBioMedicine, 2018
Background: Cancer treatment is based on tumor staging. Curative intent is only applied to localized tumors. Recent studies show that oligometastatic patients who have limited number of metastases may benefit from metastasis-directed local treatments to ...
Zhiwei Sun   +8 more
doaj   +1 more source

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

open access: yesNature Communications, 2018
The oligometastasis hypothesis suggests certain metastases are limited in extent and curable with focal therapies. Here they identify three integrated molecular subtypes of colorectal cancer liver metastasis, which complement clinical risk stratification
Sean P. Pitroda   +24 more
doaj   +1 more source

Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer

open access: yesFrontiers in Oncology
IntroductionWe compared radical prostatectomy (RP) and radiotherapy (RT) as local therapies for primary tumors and examined their associations with survival outcomes and urinary tract complications in patients with oligometastatic prostate cancer (omPC ...
Won Sik Ham   +4 more
doaj   +1 more source

Oligometastasis in the gastrointestinal tract

open access: yes
Oligometastasis describes an intermediate stage between localized and systemic tumor disease, in which a limited number of metastases with restricted organ involvement still appear amenable to local treatment.
Bruns, Christiane J   +7 more
core  

Home - About - Disclaimer - Privacy